CN Patent

CN102215828A — 包含2-氧代-1-吡咯烷衍生物的延长释放制剂

Assigned to UCB SA · Expires 2011-10-12 · 15y expired

What this patent protects

本发明涉及包含布立西坦或塞曲西坦作为活性成分的药物组合物，本发明特别涉及由在其内芯中包含该活性成分的颗粒制成的延长释放制剂。

USPTO Abstract

本发明涉及包含布立西坦或塞曲西坦作为活性成分的药物组合物，本发明特别涉及由在其内芯中包含该活性成分的颗粒制成的延长释放制剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN102215828A
Jurisdiction
CN
Classification
—
Expires
2011-10-12
Drug substance claim
No
Drug product claim
No
Assignee
UCB SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.